E. faecium (n = 167) | E. faecalis (n = 46) | p-value | |
---|---|---|---|
Source of BSIs | |||
Intra-abdominal | 65 (39, 31–46) | 19 (41, 27–56) | 0.770 |
Unknown | 53 (32, 25–39) | 10 (22, 9–34) | 0.188 |
Central venous catheter | 30 (18, 12–24) | 10 (22, 9–34) | 0.562 |
Genitourinary | 11 (7, 3–10) | 3 (7, 0–14) | 0.987 |
Pneumonia | 4 (2, 0–5) | 3 (7, 0–14) | 0.165 |
Others | 4 (2, 0–5) | 1 (2, 0–7) | 0.930 |
Type of BSIs | |||
Polymicrobial | 20 (12, 7–17) | 1 (2, 0–7) | 0.048 |
Antibiotic resistancea | |||
Ampicillin (137 vs 46)b | 118 (86, 80–92) | 4 (9, 0–7) | <0.001 |
Gentamicin (93 vs 21) b | 49 (53, 42–63) | 7 (33, 11–55) | 0.109 |
Tetracycline (105 vs 36) b | 50 (48, 38–57) | 22 (61, 44–78) | 0.162 |
Erythromycin (105 vs 36) b | 82 (78, 70–86) | 20 (56, 39–73) | 0.009 |
Ciprofloxacin (137 vs 46) b | 118 (86, 80–92) | 18 (39, 24–54) | <0.001 |
Vancomycin (167 vs 46) b | 7 (4, 1–7) | 0 (0, 0) | 0.158 |
Treatment after the onset of BSIs | |||
Appropriate antimicrobial treatment | 157 (94, 90–98) | 43 (93, 86–100) | 0.893 |
Appropriate empirical treatment | 62 (37, 30–45) | 26 (57, 42–71) | 0.018 |